Education
About Us
Working with TipRanks
Follow Us
Zai Lab (ZLAB)
NASDAQ:ZLAB
ZLAB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.48 - $36.60
Previous CloseN/A
Volume273.50K
Average Volume (3M)729.37K
Market Cap
$3.75B
Enterprise Value$1.78B
Total Cash (Recent Filing)$790.15M
Total Debt (Recent Filing)$15.15M
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Feb 27, 2025EPS Estimate
-0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.78
Shares Outstanding109,428,375
10 Day Avg. Volume925,181
30 Day Avg. Volume729,372
Standard Deviation0.19
R-Squared0.08
Alpha-0.00564
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.46
Price to Cash Flow (P/CF)-31.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.47
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.41
Enterprise Value/Ebitda-6.27
Forecast
1Y Price Target
$50.50Price Target Upside48.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Bulls Say, Bears Say
Bulls Say
Pipeline DevelopmentZLAB reported impressive initial monotherapy dose-escalation data at the 2024 EORTC-NCI-AACR symposium.
Sales GrowthNiraparib sales showed a significant year-over-year growth of 47.4% in the competitive PARP inhibitor market in China.
Bears Say
Profitability ConcernsThe market valuation metrics like P/E and EV/EBITDA are not meaningful, indicating potential concerns about profitability.
---
Ownership Overview
1.31% Insiders
19.88% Mutual Funds
21.73% Other Institutional Investors
56.33% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZLAB FAQ
What was Zai Lab’s price range in the past 12 months?
Zai Lab lowest stock price was $13.48 and its highest was $36.60 in the past 12 months.
What is Zai Lab’s market cap?
Zai Lab’s market cap is $3.75B.
When is Zai Lab’s upcoming earnings report date?
Zai Lab’s upcoming earnings report date is Feb 27, 2025 which is tomorrow.
How were Zai Lab’s earnings last quarter?
Zai Lab released its earnings results on Nov 12, 2024. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.783 by $0.743.
Is Zai Lab overvalued?
According to Wall Street analysts Zai Lab’s price is currently Undervalued.
Does Zai Lab pay dividends?
Zai Lab does not currently pay dividends.
What is Zai Lab’s EPS estimate?
Zai Lab’s EPS estimate is -0.65.
How many shares outstanding does Zai Lab have?
Zai Lab has 109,428,375 shares outstanding.
What happened to Zai Lab’s price movement after its last earnings report?
Zai Lab reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.783. Following the earnings report the stock price went down -6.851%.
Which hedge fund is a major shareholder of Zai Lab?
Currently, no hedge funds are holding shares in ZLAB
---
Zai Lab Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$50.50 (48.92% Upside)
$50.50 (48.92% Upside)
Blogger Sentiment
Bullish
ZLAB Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 503.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $214.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
65.24%
12-Months-Change
Fundamentals
Return on Equity
-34.98%
Trailing 12-Months
Asset Growth
-5.59%
Trailing 12-Months
Company Description
Zai Lab
Zai Lab Ltd. is a biopharmaceutical company, which engages in the licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need. Its product pipelines include ZL-2306, ZL-2401, FPA144, ETX2514, and ZL-2301. The company was founded by Samantha Ying Du and Marietta Wu in 2014 and is headquartered in Shanghai, China.
---
ZLAB Company Deck
---
ZLAB Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth driven by the successful launch of VYVGART, significant advancements in the pipeline, and a substantial reduction in net loss. While there were some increased R&D expenses, the overall financial health and strategic progress indicate a positive outlook.Read More>---
ZLAB Stock 12 Month Forecast
Average Price Target
$50.50
▲(48.92% Upside)
Technical Analysis
Best Analysts Covering ZLAB
1 Year
1 Year Success Rate
11/20 ratings generated profit
1 Year Average Return
+20.29%
reiterated a buy rating last month
Copying David Li's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of +20.29% per trade.
---